Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Black Diamond Therapeutics
AddedFeb 17, 2024
UpdatedJun 28, 2026
Black Diamond Therapeutics

Black Diamond Therapeutics

Public

Black Diamond Therapeutics, a US-based biotech firm, develops precision medicines for genetically-defined cancers.

HQ
Cambridge, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Black Diamond Therapeutics is a biotechnology company focused on developing precision medicines for genetically-defined cancers. Their core mission is to address broad patient populations with their innovative MasterKey therapies, which are designed to overcome cancer resistance, minimize wild-type mediated toxicities, and penetrate the brain to treat central nervous system diseases. The company primarily serves the United States market.

Black Diamond Therapeutics has made significant strides in cancer treatment, including presenting promising clinical data for their BDTX- therapy in patients with recurrent glioblastoma at the American Society of Clinical Oncology Annual Meeting. Their impact is underscored by their commitment to developing effective treatments for challenging cancer types, contributing to advancements in precision medicine.

Black Diamond Therapeutics - Similar Companies

Obsidian Therapeutics logo

Obsidian Therapeutics

obsidiantx.com

Blueprint Medicines logo

Blueprint Medicines

Kronos Bio logo

Kronos Bio

Praxis Precision Medicines logo

Praxis Precision Medicines

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Signet Therapeutics logo

Signet Therapeutics

Scorpion Therapeutics logo

Scorpion Therapeutics

Tango Therapeutics logo

Tango Therapeutics

tangotx.com

Window Therapeutics logo

Window Therapeutics

windowtx.com

Palm Therapeutics logo

Palm Therapeutics

Whitehawk Therapeutics logo

Whitehawk Therapeutics

aadibio.com

Duet BioTherapeutics logo

Duet BioTherapeutics

Advanced Cancer Therapeutics logo

Advanced Cancer Therapeutics

GO Therapeutics logo

GO Therapeutics

gotherapeutics.com

Black Diamond Therapeutics - Quick Facts

Who are Black Diamond Therapeutics' competitors?

Companies similar to Black Diamond Therapeutics include Obsidian Therapeutics, Blueprint Medicines, Kronos Bio and Praxis Precision Medicines.

When was Black Diamond Therapeutics founded?

Black Diamond Therapeutics was founded in 2017.

Where is Black Diamond Therapeutics' headquarters located?

Black Diamond Therapeutics' headquarters is located in Cambridge, MA, US.

When was Black Diamond Therapeutics' last funding round?

Black Diamond Therapeutics' most recent funding round was for $75M (USD) in June 2023.

How much has Black Diamond Therapeutics raised to-date?

As of Jun 29, 2023, Black Diamond Therapeutics has raised a total of $272.1M (USD).

How many employees does Black Diamond Therapeutics have?

Black Diamond Therapeutics has 65 employees as of Feb 12, 2024.

Black Diamond Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Drugs
Tags
  • Biotech
Unique IDs
  • ein: 814254660
  • secCik: 0001701541
  • ticker: BDTX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified